The novel approach of the medication represents a exciting breakthrough in the handling of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide targets two pathways – GLP-1 and glucose-dependent https://tirzepatidepeptide082913.blue-blogs.com/50278102/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment